Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activity
about
How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis VaccinesSerum albumin and osmolality inhibit Bdellovibrio bacteriovorus predation in human serum.The role of the exopolyphosphatase PPX in avoidance by Neisseria meningitidis of complement-mediated killing.Meningococcal disease and the complement system.A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies.Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function.Sepsis, apoptosis and complement.Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity.Functional characterization of exopolyphosphatase/guanosine pentaphosphate phosphohydrolase (PPX/GPPA) of Campylobacter jejuni.Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.Analysis of the SDS-PAGE patterns of outer membrane proteins from Escherichia coli strains that have lost the ability to form K1 antigen and varied in the susceptibility to normal human serum.Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance.Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia.Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.The sensitivity of escherichia coli strains with K1 surface antigen and rods without this antigen to the bactericidal effect of serum.
P2860
Q26782340-9FF4558C-EE3C-4AB4-AC63-0CEA7FECF0E9Q33918466-9F44EBF8-9B88-4F61-A68B-67AF00F46FBBQ34232221-794F9878-E570-478A-A1C2-AF7190F44BFAQ34376170-78C8D28A-13DD-4BFF-A03C-B16F769D9D82Q36699790-E2121EDF-395C-42ED-92CA-89431CE621E4Q36827324-D8ACE883-2BD8-4E18-8AA2-6ABB5D29A605Q37291833-8B31835D-445E-4838-BA9F-68B6EB993751Q38349640-1B4FB7C1-BBF2-4EAD-9757-CD7D1943D268Q39020867-3134473A-C8CF-426D-96C7-EF0165B5ABB1Q39200048-0AAFD853-7AD6-4B4B-B52E-5534AF409B39Q41867568-AD6F0A16-0CA1-4126-A0A2-6EA1302CE93EQ43749260-53BC04B5-FC7A-4010-83F5-1F608BEBDFC4Q47812166-FDDC170A-7642-4B12-B579-793767796F40Q50277552-E0D4B716-F96E-40DC-9EB8-139C0BDCCCB7Q51662938-C266D137-C7A8-4888-A389-9F1D3A0443C2Q54496398-9D9F16AF-7E8D-4DC6-8D7F-56F2DDB57F8D
P2860
Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activity
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Complement activation and form ...... of serum bactericidal activity
@en
Complement activation and form ...... f serum bactericidal activity.
@nl
type
label
Complement activation and form ...... of serum bactericidal activity
@en
Complement activation and form ...... f serum bactericidal activity.
@nl
prefLabel
Complement activation and form ...... of serum bactericidal activity
@en
Complement activation and form ...... f serum bactericidal activity.
@nl
P2093
P2860
P1476
Complement activation and form ...... of serum bactericidal activity
@en
P2093
E J Kuijper
M Drogari-Apiranthitou
P2860
P304
P356
10.1128/IAI.70.7.3752-3758.2002
P407
P577
2002-07-01T00:00:00Z